PE(18:1(11Z)/22:4(7Z,10Z,13Z,16Z))
|
Basic information |
| Metabolite name | PE(18:1(11Z)/22:4(7Z,10Z,13Z,16Z)) |
 | HMDB0009042 |
 |
C00350 |
 |
53479640 |
| Synonyms | NA |
| No. of studies | 1 |
|
Basic information |
| Metabolite name | PE(18:1(11Z)/22:4(7Z,10Z,13Z,16Z)) |
| HMDB0009042 |
|
C00350 |
|
53479640 |
| Synonyms | NA |
| No. of studies | 1 |
|
Relationship between PE(18:1(11Z)/22:4(7Z,10Z,13Z,16Z)) and depression (count: 1) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M1098 | Type1 | CUMS group vs. control group | Hippocampus | Sprague-Dawley rat | Up |
| Study M1098 | Type2 | CUMS + fluoxetine group vs. CUMS group | Hippocampus | Sprague-Dawley rat | Down |
| Study M1098 | Type2 | CUMS + L-theanine group vs. CUMS group | Hippocampus | Sprague-Dawley rat | Down |